{"id":"W2945060451","doi":"10.1177/1753466619850725","title":"Aclidinium bromide in fixed-dose combination with formoterol fumarate in the management of COPD: an update on the evidence base","year":2019,"lang":"en","type":"review","venue":"Therapeutic Advances in Respiratory Disease","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Medicine; COPD; Lama; Formoterol; Formoterol Fumarate; Bronchodilator; Quality of life (healthcare); Tiotropium bromide; Obstructive lung disease; Clinical trial; Internal medicine; Minimal clinically important difference; Muscarinic antagonist; Intensive care medicine; Physical therapy; Corticosteroid; Asthma; Randomized controlled trial; Lung; Lung function; Budesonide; Antagonist","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001869466,0.0006514123,0.001320507,0.0005887945,0.00007624694,0.00004508982,0.001121014,0.0001371206,0.0001244647],"category_scores_gemma":[0.00006600779,0.0003665003,0.0002538638,0.00129407,0.0004390495,0.0006032623,0.0001622939,0.0009833314,0.00005802684],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008133571,"about_ca_system_score_gemma":0.0007779362,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001051833,"about_ca_topic_score_gemma":0.00004439225,"domain_scores_codex":[0.9942979,0.001867861,0.001046327,0.0009345767,0.001203958,0.000649363],"domain_scores_gemma":[0.9962648,0.0008718593,0.0005290012,0.002014905,0.0001035265,0.0002158938],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003521323,0.001543551,0.002108532,0.03827283,0.000147653,0.0008642863,0.000136917,0.0001897736,0.000001393818,0.003346712,0.00001420382,0.9498528],"study_design_scores_gemma":[0.01896031,0.003434799,0.1325026,0.2126218,0.004162581,0.00002883952,0.002740609,0.002210143,0.00001520716,0.004203219,0.6166162,0.002503739],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01429531,0.9775888,0.00002103571,0.0002915572,0.0001008981,0.007174851,0.00009515041,0.00002246112,0.0004098911],"genre_scores_gemma":[0.0742913,0.9224558,0.00002080544,0.001510308,0.00005245953,0.001421313,0.00008409197,0.00009677977,0.00006713728],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9473491,"threshold_uncertainty_score":0.9998787,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1079027651964468,"score_gpt":0.405512090307414,"score_spread":0.2976093251109672,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}